Who owns the T ACELLT APEIRON CELL THERAPIES trademark?

The T ACELLT APEIRON CELL THERAPIES trademark is owned by APEIRON Biologics GmbH.

What is the serial number for T ACELLT APEIRON CELL THERAPIES?

The USPTO serial number for T ACELLT APEIRON CELL THERAPIES is 79294724.

What is the registration number for T ACELLT APEIRON CELL THERAPIES?

T ACELLT APEIRON CELL THERAPIES is registered under USPTO registration number 6799401.

TAC

USPTO Trademark Record

REGISTERED

T ACELLT APEIRON CELL THERAPIES

Q: What class is the T ACELLT APEIRON CELL THERAPIES trademark registered in?

The T ACELLT APEIRON CELL THERAPIES trademark is registered in Class 001 (Chemicals for industrial, scientific & agricultural use), Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 79294724·Reg 6799401·Filed Aug 03, 2020

Owner APEIRON Biologics GmbH

Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; fire extinguishing and fire prevention compositions; tempering and soldering preparations; substances for tanning animal skins and hides; adhesives for use in industry; compost, manures, fertilizers; biological preparations for use in industry and science.; Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

T ACELLT APEIRON CELL THERAPIES (Serial No. 79294724), Registration No. 6799401, is a registered US trademark filed on Aug 03, 2020 by APEIRON Biologics GmbH. This trademark covers Class 001 (Chemicals for industrial, scientific & agricultural use), Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

early section 8: July 26, 2028

Mark Intelligence

T ACELLT APEIRON CELL THERAPIES (Reg. #6799401) is a registered US trademark that has been protecting its owner, APEIRON Biologics GmbH, since 2020. The mark covers Class 001 (Chemicals for industrial, scientific & agricultural use), Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocesse.... The mark faced 6 opposition proceedings during prosecution.

FILED

Aug 03, 2020

SERIAL

79294724

REG#

6799401

REGISTERED

Jul 26, 2022

Owner

Applicant

APEIRON Biologics GmbH

Entity

Corporation (Foreign)

Address

Campus-Vienna-Biocenter 5, A-1030 Wien

Country

Attorney

NameJulianne Abelman

Law firm

Julianne Abelman Womble Bond Dickinson (US) LLP

Docket

403146

Address

950 3rd Avenue, Suite 2400, New York, NY 10022, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateAug 03, 2020

Serial Number79294724

Registration No.6799401

Registration DateJul 26, 2022

Status DateJul 26, 2022

Published for OppositionMay 10, 2022

Mark TypeDesign with words

Attorney Docket403146

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 6× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 001Chemicals for industrial, scientific & agricultural use

US codes: 001, 005, 006, 010, 026, 046

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

44 events

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

Aug 11, 2026

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED

May 09, 2025

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED

CHANGE OF NAME/ADDRESS REC'D FROM IB

Jan 16, 2025

CHANGE OF NAME/ADDRESS REC'D FROM IB

NEW REPRESENTATIVE AT IB RECEIVED

Nov 04, 2023

NEW REPRESENTATIVE AT IB RECEIVED

FINAL DECISION TRANSACTION PROCESSED BY IB

Nov 20, 2022

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION NOTICE SENT TO IB

Oct 28, 2022

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION PROCESSED

Oct 27, 2022

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Oct 26, 2022

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Jul 26, 2022

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 26, 2022

NOTICE OF REGISTRATION CONFIRMATION EMAILED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jul 20, 2022

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jul 20, 2022

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Jul 20, 2022

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 20, 2022

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NOTIFICATION PROCESSED BY IB

May 15, 2022

NOTIFICATION PROCESSED BY IB

PUBLISHED FOR OPPOSITION

May 10, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 10, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 20, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Apr 20, 2022

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Apr 20, 2022

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

EXAMINERS AMENDMENT -WRITTEN

Apr 04, 2022

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Apr 04, 2022

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 04, 2022

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Apr 04, 2022

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 04, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Mar 21, 2022

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Mar 02, 2022

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Mar 02, 2022

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

NEW REPRESENTATIVE AT IB RECEIVED

Nov 26, 2021

NEW REPRESENTATIVE AT IB RECEIVED

FINAL REFUSAL WRITTEN

Jun 23, 2021

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Jun 23, 2021

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Jun 23, 2021

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

May 20, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 19, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 19, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

REFUSAL PROCESSED BY IB

Dec 27, 2020

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Dec 09, 2020

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Dec 09, 2020

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Dec 01, 2020

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Nov 30, 2020

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Nov 24, 2020

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Oct 09, 2020

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 05, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Oct 01, 2020

SN ASSIGNED FOR SECT 66A APPL FROM IB

T ACELLT APEIRON CELL THERAPIES

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by APEIRON Biologics GmbH

Other Marks in Class 001 — Chemicals for industrial, scientific & agricultural use

Other Marks by Julianne Abelman

Resources

Company